Come Learn About A-T Trials That Have Data To Share!
10.00 AM EST: Welcome and introductions by Cynthia Rothblum-Oviatt 10.05: David Coman: Triheptanoin - A trial in progress for A-T (recorded presentation) 10.20: Discussion (note this will not be Q&A style) 10.30: David Lynch: Omaveloxolone - Presentation of findings with Friedreich’s ataxia and insights on clinical trial design for rare diseases 10.55 Q&A and Discussion 11.10: Helena Donath: Potential biomarkers for A-T – NF-L and miRNA 11.25: Q&A and Discussion 11.35: Howard Lederman: Finding biomarkers for A-T – potential for an in-depth session 11.50: General discussion - Biomarkers 12.00: Last minute Q&A / Discussion for all speakers 12.30: Adjourn
After registering, you will receive a confirmation email containing information about joining the meeting. If you have any registration questions, please contact Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo. with the A-T Society.
A-TCRN Questions? Contact
Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo. | Esta dirección de correo electrónico está siendo protegida contra los robots de spam. Necesita tener JavaScript habilitado para poder verlo.
